nodes	percent_of_prediction	percent_of_DWPC	metapath
Domperidone—Pimozide—Ezetimibe—atherosclerosis	0.453	1	CrCrCtD
Domperidone—CYP3A7—Simvastatin—atherosclerosis	0.0285	0.0646	CbGbCtD
Domperidone—CYP3A7-CYP3A51P—Simvastatin—atherosclerosis	0.0285	0.0646	CbGbCtD
Domperidone—CYP3A7—Lovastatin—atherosclerosis	0.0279	0.0633	CbGbCtD
Domperidone—CYP3A7-CYP3A51P—Lovastatin—atherosclerosis	0.0279	0.0633	CbGbCtD
Domperidone—CYP2B6—Simvastatin—atherosclerosis	0.0272	0.0616	CbGbCtD
Domperidone—CYP3A5—Rosuvastatin—atherosclerosis	0.023	0.0522	CbGbCtD
Domperidone—CYP3A5—Simvastatin—atherosclerosis	0.0214	0.0485	CbGbCtD
Domperidone—CYP3A5—Pravastatin—atherosclerosis	0.021	0.0474	CbGbCtD
Domperidone—CYP3A5—Lovastatin—atherosclerosis	0.021	0.0474	CbGbCtD
Domperidone—CYP2C8—Simvastatin—atherosclerosis	0.0206	0.0466	CbGbCtD
Domperidone—CYP2C8—Pravastatin—atherosclerosis	0.0202	0.0456	CbGbCtD
Domperidone—CYP2C8—Lovastatin—atherosclerosis	0.0202	0.0456	CbGbCtD
Domperidone—CYP2D6—Niacin—atherosclerosis	0.0166	0.0376	CbGbCtD
Domperidone—ABCB1—Ezetimibe—atherosclerosis	0.015	0.0339	CbGbCtD
Domperidone—ABCB1—Simvastatin—atherosclerosis	0.0139	0.0316	CbGbCtD
Domperidone—ABCB1—Lovastatin—atherosclerosis	0.0136	0.0309	CbGbCtD
Domperidone—ABCB1—Pravastatin—atherosclerosis	0.0136	0.0309	CbGbCtD
Domperidone—CYP2D6—Simvastatin—atherosclerosis	0.0131	0.0297	CbGbCtD
Domperidone—CYP2D6—Lovastatin—atherosclerosis	0.0129	0.0291	CbGbCtD
Domperidone—CYP2D6—Pravastatin—atherosclerosis	0.0129	0.0291	CbGbCtD
Domperidone—CYP3A4—Ezetimibe—atherosclerosis	0.00898	0.0203	CbGbCtD
Domperidone—CYP3A4—Rosuvastatin—atherosclerosis	0.00898	0.0203	CbGbCtD
Domperidone—CYP3A4—Simvastatin—atherosclerosis	0.00835	0.0189	CbGbCtD
Domperidone—CYP3A4—Lovastatin—atherosclerosis	0.00817	0.0185	CbGbCtD
Domperidone—CYP3A4—Pravastatin—atherosclerosis	0.00817	0.0185	CbGbCtD
Domperidone—Regurgitation—Lovastatin—atherosclerosis	0.00525	0.0845	CcSEcCtD
Domperidone—Regurgitation—Simvastatin—atherosclerosis	0.00491	0.0791	CcSEcCtD
Domperidone—Heartburn—Niacin—atherosclerosis	0.0016	0.0258	CcSEcCtD
Domperidone—Heartburn—Pravastatin—atherosclerosis	0.00157	0.0254	CcSEcCtD
Domperidone—Gynaecomastia—Rosuvastatin—atherosclerosis	0.00135	0.0218	CcSEcCtD
Domperidone—Breast pain—Niacin—atherosclerosis	0.00126	0.0203	CcSEcCtD
Domperidone—Bepotastine—HRH1—atherosclerosis	0.0012	0.329	CrCbGaD
Domperidone—Gynaecomastia—Lovastatin—atherosclerosis	0.00115	0.0185	CcSEcCtD
Domperidone—Gynaecomastia—Simvastatin—atherosclerosis	0.00107	0.0173	CcSEcCtD
Domperidone—Cramps of lower extremities—Niacin—atherosclerosis	0.00101	0.0163	CcSEcCtD
Domperidone—Hot flush—Ezetimibe—atherosclerosis	0.000975	0.0157	CcSEcCtD
Domperidone—Gynaecomastia—Pravastatin—atherosclerosis	0.000969	0.0156	CcSEcCtD
Domperidone—Menopausal symptoms—Ezetimibe—atherosclerosis	0.000967	0.0156	CcSEcCtD
Domperidone—Hot flush—Pravastatin—atherosclerosis	0.000841	0.0135	CcSEcCtD
Domperidone—Menopausal symptoms—Pravastatin—atherosclerosis	0.000834	0.0134	CcSEcCtD
Domperidone—Migraine—Niacin—atherosclerosis	0.000786	0.0127	CcSEcCtD
Domperidone—Arrhythmia—Rosuvastatin—atherosclerosis	0.000678	0.0109	CcSEcCtD
Domperidone—Sertindole—HRH1—atherosclerosis	0.000651	0.178	CrCbGaD
Domperidone—Dysuria—Pravastatin—atherosclerosis	0.000636	0.0102	CcSEcCtD
Domperidone—Stomatitis—Niacin—atherosclerosis	0.0006	0.00966	CcSEcCtD
Domperidone—Muscle spasms—Lovastatin—atherosclerosis	0.000539	0.00867	CcSEcCtD
Domperidone—Muscle spasms—Ezetimibe—atherosclerosis	0.000528	0.00851	CcSEcCtD
Domperidone—Muscle spasms—Simvastatin—atherosclerosis	0.000504	0.00811	CcSEcCtD
Domperidone—Arrhythmia—Niacin—atherosclerosis	0.000494	0.00795	CcSEcCtD
Domperidone—Insomnia—Rosuvastatin—atherosclerosis	0.000488	0.00786	CcSEcCtD
Domperidone—Arrhythmia—Pravastatin—atherosclerosis	0.000486	0.00783	CcSEcCtD
Domperidone—Palpitations—Ezetimibe—atherosclerosis	0.000486	0.00782	CcSEcCtD
Domperidone—Dyspepsia—Rosuvastatin—atherosclerosis	0.000475	0.00765	CcSEcCtD
Domperidone—Tension—Niacin—atherosclerosis	0.000472	0.0076	CcSEcCtD
Domperidone—Nervousness—Niacin—atherosclerosis	0.000467	0.00753	CcSEcCtD
Domperidone—Dry mouth—Lovastatin—atherosclerosis	0.000466	0.00751	CcSEcCtD
Domperidone—Tension—Pravastatin—atherosclerosis	0.000465	0.00749	CcSEcCtD
Domperidone—Muscle spasms—Niacin—atherosclerosis	0.000463	0.00745	CcSEcCtD
Domperidone—Constipation—Rosuvastatin—atherosclerosis	0.000461	0.00743	CcSEcCtD
Domperidone—Nervousness—Pravastatin—atherosclerosis	0.00046	0.00741	CcSEcCtD
Domperidone—Dry mouth—Ezetimibe—atherosclerosis	0.000457	0.00737	CcSEcCtD
Domperidone—Muscle spasms—Pravastatin—atherosclerosis	0.000455	0.00733	CcSEcCtD
Domperidone—Urticaria—Rosuvastatin—atherosclerosis	0.000429	0.0069	CcSEcCtD
Domperidone—Oedema—Simvastatin—atherosclerosis	0.000428	0.00689	CcSEcCtD
Domperidone—Abdominal pain—Rosuvastatin—atherosclerosis	0.000426	0.00687	CcSEcCtD
Domperidone—Palpitations—Niacin—atherosclerosis	0.000425	0.00685	CcSEcCtD
Domperidone—Insomnia—Lovastatin—atherosclerosis	0.000413	0.00666	CcSEcCtD
Domperidone—Insomnia—Ezetimibe—atherosclerosis	0.000406	0.00653	CcSEcCtD
Domperidone—Dyspepsia—Lovastatin—atherosclerosis	0.000402	0.00648	CcSEcCtD
Domperidone—Dry mouth—Niacin—atherosclerosis	0.000401	0.00645	CcSEcCtD
Domperidone—Zuclopenthixol—HRH1—atherosclerosis	0.000396	0.109	CrCbGaD
Domperidone—Pimozide—HRH1—atherosclerosis	0.000396	0.109	CrCbGaD
Domperidone—Dyspepsia—Ezetimibe—atherosclerosis	0.000395	0.00636	CcSEcCtD
Domperidone—Oedema—Niacin—atherosclerosis	0.000393	0.00632	CcSEcCtD
Domperidone—Constipation—Lovastatin—atherosclerosis	0.000391	0.0063	CcSEcCtD
Domperidone—Asthenia—Rosuvastatin—atherosclerosis	0.000387	0.00623	CcSEcCtD
Domperidone—Insomnia—Simvastatin—atherosclerosis	0.000387	0.00623	CcSEcCtD
Domperidone—Oedema—Pravastatin—atherosclerosis	0.000387	0.00623	CcSEcCtD
Domperidone—Constipation—Ezetimibe—atherosclerosis	0.000383	0.00618	CcSEcCtD
Domperidone—Pruritus—Rosuvastatin—atherosclerosis	0.000382	0.00615	CcSEcCtD
Domperidone—Dyspepsia—Simvastatin—atherosclerosis	0.000376	0.00606	CcSEcCtD
Domperidone—Diarrhoea—Rosuvastatin—atherosclerosis	0.000369	0.00594	CcSEcCtD
Domperidone—Hypotension—Niacin—atherosclerosis	0.000367	0.00591	CcSEcCtD
Domperidone—Constipation—Simvastatin—atherosclerosis	0.000366	0.00589	CcSEcCtD
Domperidone—Trazodone—HRH1—atherosclerosis	0.000365	0.1	CrCbGaD
Domperidone—Urticaria—Lovastatin—atherosclerosis	0.000363	0.00585	CcSEcCtD
Domperidone—Abdominal pain—Lovastatin—atherosclerosis	0.000361	0.00582	CcSEcCtD
Domperidone—Dizziness—Rosuvastatin—atherosclerosis	0.000357	0.00575	CcSEcCtD
Domperidone—Urticaria—Ezetimibe—atherosclerosis	0.000356	0.00574	CcSEcCtD
Domperidone—Insomnia—Niacin—atherosclerosis	0.000355	0.00572	CcSEcCtD
Domperidone—Abdominal pain—Ezetimibe—atherosclerosis	0.000354	0.00571	CcSEcCtD
Domperidone—Insomnia—Pravastatin—atherosclerosis	0.00035	0.00563	CcSEcCtD
Domperidone—Somnolence—Niacin—atherosclerosis	0.000349	0.00562	CcSEcCtD
Domperidone—Dyspepsia—Niacin—atherosclerosis	0.000346	0.00557	CcSEcCtD
Domperidone—Dyspepsia—Pravastatin—atherosclerosis	0.00034	0.00548	CcSEcCtD
Domperidone—Rash—Rosuvastatin—atherosclerosis	0.00034	0.00548	CcSEcCtD
Domperidone—Dermatitis—Rosuvastatin—atherosclerosis	0.00034	0.00547	CcSEcCtD
Domperidone—Urticaria—Simvastatin—atherosclerosis	0.00034	0.00547	CcSEcCtD
Domperidone—Abdominal pain—Simvastatin—atherosclerosis	0.000338	0.00544	CcSEcCtD
Domperidone—Headache—Rosuvastatin—atherosclerosis	0.000338	0.00544	CcSEcCtD
Domperidone—Constipation—Pravastatin—atherosclerosis	0.000331	0.00532	CcSEcCtD
Domperidone—Asthenia—Lovastatin—atherosclerosis	0.000328	0.00528	CcSEcCtD
Domperidone—Prochlorperazine—HRH1—atherosclerosis	0.000327	0.0896	CrCbGaD
Domperidone—Pruritus—Lovastatin—atherosclerosis	0.000323	0.00521	CcSEcCtD
Domperidone—Asthenia—Ezetimibe—atherosclerosis	0.000322	0.00518	CcSEcCtD
Domperidone—Nausea—Rosuvastatin—atherosclerosis	0.00032	0.00516	CcSEcCtD
Domperidone—Pruritus—Ezetimibe—atherosclerosis	0.000317	0.00511	CcSEcCtD
Domperidone—Diarrhoea—Lovastatin—atherosclerosis	0.000313	0.00504	CcSEcCtD
Domperidone—Urticaria—Niacin—atherosclerosis	0.000312	0.00502	CcSEcCtD
Domperidone—Abdominal pain—Niacin—atherosclerosis	0.00031	0.005	CcSEcCtD
Domperidone—Urticaria—Pravastatin—atherosclerosis	0.000307	0.00495	CcSEcCtD
Domperidone—Asthenia—Simvastatin—atherosclerosis	0.000307	0.00494	CcSEcCtD
Domperidone—Diarrhoea—Ezetimibe—atherosclerosis	0.000307	0.00494	CcSEcCtD
Domperidone—Abdominal pain—Pravastatin—atherosclerosis	0.000306	0.00492	CcSEcCtD
Domperidone—Pruritus—Simvastatin—atherosclerosis	0.000303	0.00487	CcSEcCtD
Domperidone—Dizziness—Lovastatin—atherosclerosis	0.000302	0.00487	CcSEcCtD
Domperidone—Dizziness—Ezetimibe—atherosclerosis	0.000297	0.00478	CcSEcCtD
Domperidone—Diarrhoea—Simvastatin—atherosclerosis	0.000293	0.00471	CcSEcCtD
Domperidone—Vomiting—Lovastatin—atherosclerosis	0.000291	0.00468	CcSEcCtD
Domperidone—Rash—Lovastatin—atherosclerosis	0.000288	0.00464	CcSEcCtD
Domperidone—Dermatitis—Lovastatin—atherosclerosis	0.000288	0.00464	CcSEcCtD
Domperidone—Headache—Lovastatin—atherosclerosis	0.000286	0.00461	CcSEcCtD
Domperidone—Vomiting—Ezetimibe—atherosclerosis	0.000285	0.00459	CcSEcCtD
Domperidone—Dizziness—Simvastatin—atherosclerosis	0.000283	0.00455	CcSEcCtD
Domperidone—Rash—Ezetimibe—atherosclerosis	0.000283	0.00455	CcSEcCtD
Domperidone—Dermatitis—Ezetimibe—atherosclerosis	0.000282	0.00455	CcSEcCtD
Domperidone—Asthenia—Niacin—atherosclerosis	0.000282	0.00454	CcSEcCtD
Domperidone—Headache—Ezetimibe—atherosclerosis	0.000281	0.00452	CcSEcCtD
Domperidone—Pruritus—Niacin—atherosclerosis	0.000278	0.00447	CcSEcCtD
Domperidone—Asthenia—Pravastatin—atherosclerosis	0.000277	0.00447	CcSEcCtD
Domperidone—Pruritus—Pravastatin—atherosclerosis	0.000274	0.00441	CcSEcCtD
Domperidone—Vomiting—Simvastatin—atherosclerosis	0.000272	0.00438	CcSEcCtD
Domperidone—Nausea—Lovastatin—atherosclerosis	0.000272	0.00437	CcSEcCtD
Domperidone—Rash—Simvastatin—atherosclerosis	0.00027	0.00434	CcSEcCtD
Domperidone—Dermatitis—Simvastatin—atherosclerosis	0.000269	0.00434	CcSEcCtD
Domperidone—Diarrhoea—Niacin—atherosclerosis	0.000269	0.00433	CcSEcCtD
Domperidone—Headache—Simvastatin—atherosclerosis	0.000268	0.00431	CcSEcCtD
Domperidone—Nausea—Ezetimibe—atherosclerosis	0.000266	0.00429	CcSEcCtD
Domperidone—Diarrhoea—Pravastatin—atherosclerosis	0.000265	0.00426	CcSEcCtD
Domperidone—Dizziness—Niacin—atherosclerosis	0.00026	0.00418	CcSEcCtD
Domperidone—Dizziness—Pravastatin—atherosclerosis	0.000256	0.00412	CcSEcCtD
Domperidone—Nausea—Simvastatin—atherosclerosis	0.000254	0.00409	CcSEcCtD
Domperidone—Vomiting—Niacin—atherosclerosis	0.00025	0.00402	CcSEcCtD
Domperidone—Rash—Niacin—atherosclerosis	0.000248	0.00399	CcSEcCtD
Domperidone—Dermatitis—Niacin—atherosclerosis	0.000247	0.00398	CcSEcCtD
Domperidone—Headache—Niacin—atherosclerosis	0.000246	0.00396	CcSEcCtD
Domperidone—Vomiting—Pravastatin—atherosclerosis	0.000246	0.00396	CcSEcCtD
Domperidone—Rash—Pravastatin—atherosclerosis	0.000244	0.00393	CcSEcCtD
Domperidone—Dermatitis—Pravastatin—atherosclerosis	0.000244	0.00392	CcSEcCtD
Domperidone—Headache—Pravastatin—atherosclerosis	0.000242	0.0039	CcSEcCtD
Domperidone—Perphenazine—HRH1—atherosclerosis	0.000234	0.064	CrCbGaD
Domperidone—Nausea—Niacin—atherosclerosis	0.000233	0.00376	CcSEcCtD
Domperidone—Nausea—Pravastatin—atherosclerosis	0.00023	0.0037	CcSEcCtD
Domperidone—Pipotiazine—ALB—atherosclerosis	7.89e-05	0.0216	CrCbGaD
Domperidone—ABCB1—Metabolism—SCARB1—atherosclerosis	6.15e-06	0.000155	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—AGT—atherosclerosis	6.14e-06	0.000155	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	6.11e-06	0.000154	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—CETP—atherosclerosis	6.05e-06	0.000153	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	6.05e-06	0.000153	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	6.04e-06	0.000152	CbGpPWpGaD
Domperidone—CYP2B6—Metabolism—HMOX1—atherosclerosis	6.02e-06	0.000152	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	6.02e-06	0.000152	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—APOE—atherosclerosis	6.01e-06	0.000152	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—LEP—atherosclerosis	6.01e-06	0.000152	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—ALOX5—atherosclerosis	5.96e-06	0.000151	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—CAV1—atherosclerosis	5.96e-06	0.00015	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—MMP3—atherosclerosis	5.95e-06	0.00015	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism—ABCA1—atherosclerosis	5.94e-06	0.00015	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—APOA1—atherosclerosis	5.94e-06	0.00015	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—IGF2—atherosclerosis	5.92e-06	0.000149	CbGpPWpGaD
Domperidone—CYP3A5—Metabolism—HMOX1—atherosclerosis	5.89e-06	0.000149	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—HMGCR—atherosclerosis	5.81e-06	0.000147	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—SCARB1—atherosclerosis	5.8e-06	0.000146	CbGpPWpGaD
Domperidone—CYP2B6—Metabolism—APOB—atherosclerosis	5.77e-06	0.000146	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—APOB—atherosclerosis	5.75e-06	0.000145	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—ESR1—atherosclerosis	5.74e-06	0.000145	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—CYP27A1—atherosclerosis	5.71e-06	0.000144	CbGpPWpGaD
Domperidone—DRD2—GPCR downstream signaling—CXCL8—atherosclerosis	5.7e-06	0.000144	CbGpPWpGaD
Domperidone—ABCB1—Transmembrane transport of small molecules—ALB—atherosclerosis	5.7e-06	0.000144	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—F2—atherosclerosis	5.67e-06	0.000143	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—EDN1—atherosclerosis	5.66e-06	0.000143	CbGpPWpGaD
Domperidone—CYP3A5—Metabolism—APOB—atherosclerosis	5.64e-06	0.000142	CbGpPWpGaD
Domperidone—CYP3A7—Metabolism—PIK3CG—atherosclerosis	5.64e-06	0.000142	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—CCL5—atherosclerosis	5.61e-06	0.000142	CbGpPWpGaD
Domperidone—CYP2B6—Metabolism—GSTM1—atherosclerosis	5.61e-06	0.000142	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	5.51e-06	0.000139	CbGpPWpGaD
Domperidone—CYP2B6—Metabolism—LPL—atherosclerosis	5.51e-06	0.000139	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—LPL—atherosclerosis	5.49e-06	0.000139	CbGpPWpGaD
Domperidone—CYP3A5—Metabolism—GSTM1—atherosclerosis	5.49e-06	0.000138	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—HMGCR—atherosclerosis	5.48e-06	0.000138	CbGpPWpGaD
Domperidone—CYP3A7—Metabolism—PPARG—atherosclerosis	5.44e-06	0.000137	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—PIK3CG—atherosclerosis	5.43e-06	0.000137	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—ALOX15—atherosclerosis	5.41e-06	0.000137	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—APOA2—atherosclerosis	5.41e-06	0.000137	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—PLA2G2A—atherosclerosis	5.41e-06	0.000137	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—ALOX5AP—atherosclerosis	5.41e-06	0.000137	CbGpPWpGaD
Domperidone—CYP3A5—Metabolism—LPL—atherosclerosis	5.39e-06	0.000136	CbGpPWpGaD
Domperidone—CYP2B6—Metabolism—GPX1—atherosclerosis	5.38e-06	0.000136	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—NAMPT—atherosclerosis	5.35e-06	0.000135	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—ABCG5—atherosclerosis	5.35e-06	0.000135	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—PRKCG—atherosclerosis	5.34e-06	0.000135	CbGpPWpGaD
Domperidone—CYP3A7—Metabolism—INS—atherosclerosis	5.34e-06	0.000135	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	5.32e-06	0.000134	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—LIPC—atherosclerosis	5.32e-06	0.000134	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—APOC3—atherosclerosis	5.28e-06	0.000133	CbGpPWpGaD
Domperidone—CYP3A5—Metabolism—GPX1—atherosclerosis	5.25e-06	0.000133	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—LDLR—atherosclerosis	5.25e-06	0.000133	CbGpPWpGaD
Domperidone—CYP2B6—Metabolism—CD36—atherosclerosis	5.24e-06	0.000132	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—SPP1—atherosclerosis	5.2e-06	0.000131	CbGpPWpGaD
Domperidone—DRD3—Signaling by GPCR—MAPK3—atherosclerosis	5.2e-06	0.000131	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—ABCA1—atherosclerosis	5.18e-06	0.000131	CbGpPWpGaD
Domperidone—DRD2—Signaling by GPCR—CXCL8—atherosclerosis	5.18e-06	0.000131	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—LPA—atherosclerosis	5.16e-06	0.00013	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—INS—atherosclerosis	5.14e-06	0.00013	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—CETP—atherosclerosis	5.13e-06	0.000129	CbGpPWpGaD
Domperidone—CYP3A5—Metabolism—CD36—atherosclerosis	5.12e-06	0.000129	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism—HMOX1—atherosclerosis	5.1e-06	0.000129	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—CCL2—atherosclerosis	5.05e-06	0.000128	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—BGN—atherosclerosis	5e-06	0.000126	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—IGF1—atherosclerosis	4.97e-06	0.000125	CbGpPWpGaD
Domperidone—CYP2B6—Metabolism—MTHFR—atherosclerosis	4.96e-06	0.000125	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—APOA5—atherosclerosis	4.95e-06	0.000125	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—SCARB1—atherosclerosis	4.91e-06	0.000124	CbGpPWpGaD
Domperidone—CYP3A7—Metabolism—ALB—atherosclerosis	4.89e-06	0.000123	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism—APOB—atherosclerosis	4.89e-06	0.000123	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—ABCA1—atherosclerosis	4.88e-06	0.000123	CbGpPWpGaD
Domperidone—CYP2B6—Metabolism—PPARA—atherosclerosis	4.87e-06	0.000123	CbGpPWpGaD
Domperidone—CYP3A5—Metabolism—MTHFR—atherosclerosis	4.85e-06	0.000122	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—PDGFB—atherosclerosis	4.81e-06	0.000121	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	4.78e-06	0.000121	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—PLA2G1B—atherosclerosis	4.77e-06	0.00012	CbGpPWpGaD
Domperidone—CYP3A5—Metabolism—PPARA—atherosclerosis	4.76e-06	0.00012	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism—GSTM1—atherosclerosis	4.75e-06	0.00012	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—SERPINE1—atherosclerosis	4.72e-06	0.000119	CbGpPWpGaD
Domperidone—CYP2B6—Metabolism—AGT—atherosclerosis	4.71e-06	0.000119	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—AGT—atherosclerosis	4.7e-06	0.000119	CbGpPWpGaD
Domperidone—CYP3A7—Metabolism—NOS3—atherosclerosis	4.68e-06	0.000118	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism—LPL—atherosclerosis	4.66e-06	0.000118	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—HMGCR—atherosclerosis	4.64e-06	0.000117	CbGpPWpGaD
Domperidone—CYP2B6—Metabolism—APOE—atherosclerosis	4.62e-06	0.000117	CbGpPWpGaD
Domperidone—CYP3A5—Metabolism—AGT—atherosclerosis	4.61e-06	0.000116	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—ALOX5—atherosclerosis	4.6e-06	0.000116	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—LEP—atherosclerosis	4.6e-06	0.000116	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—APOE—atherosclerosis	4.6e-06	0.000116	CbGpPWpGaD
Domperidone—CYP2B6—Metabolism—CAV1—atherosclerosis	4.58e-06	0.000115	CbGpPWpGaD
Domperidone—CYP2B6—Metabolism—APOA1—atherosclerosis	4.57e-06	0.000115	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—CAV1—atherosclerosis	4.56e-06	0.000115	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism—GPX1—atherosclerosis	4.55e-06	0.000115	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—APOA1—atherosclerosis	4.55e-06	0.000115	CbGpPWpGaD
Domperidone—CYP3A5—Metabolism—APOE—atherosclerosis	4.51e-06	0.000114	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—NOS3—atherosclerosis	4.51e-06	0.000114	CbGpPWpGaD
Domperidone—CYP3A5—Metabolism—CAV1—atherosclerosis	4.47e-06	0.000113	CbGpPWpGaD
Domperidone—CYP3A5—Metabolism—APOA1—atherosclerosis	4.46e-06	0.000113	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—HMOX1—atherosclerosis	4.44e-06	0.000112	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism—CD36—atherosclerosis	4.43e-06	0.000112	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—ESR1—atherosclerosis	4.39e-06	0.000111	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—F2—atherosclerosis	4.34e-06	0.00011	CbGpPWpGaD
Domperidone—CYP3A7—Metabolism—PTGS2—atherosclerosis	4.28e-06	0.000108	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—APOB—atherosclerosis	4.26e-06	0.000107	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism—MTHFR—atherosclerosis	4.2e-06	0.000106	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—HMOX1—atherosclerosis	4.19e-06	0.000106	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	4.18e-06	0.000106	CbGpPWpGaD
Domperidone—CYP2B6—Metabolism—PIK3CG—atherosclerosis	4.17e-06	0.000105	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—PIK3CG—atherosclerosis	4.15e-06	0.000105	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—GSTM1—atherosclerosis	4.14e-06	0.000105	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—ABCA1—atherosclerosis	4.13e-06	0.000104	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—NAMPT—atherosclerosis	4.13e-06	0.000104	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism—PPARA—atherosclerosis	4.12e-06	0.000104	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—LIPC—atherosclerosis	4.1e-06	0.000104	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—APOC3—atherosclerosis	4.08e-06	0.000103	CbGpPWpGaD
Domperidone—CYP3A5—Metabolism—PIK3CG—atherosclerosis	4.07e-06	0.000103	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—LPL—atherosclerosis	4.06e-06	0.000103	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—LDLR—atherosclerosis	4.05e-06	0.000102	CbGpPWpGaD
Domperidone—CYP2B6—Metabolism—PPARG—atherosclerosis	4.02e-06	0.000102	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—APOB—atherosclerosis	4.01e-06	0.000101	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—CXCL8—atherosclerosis	4e-06	0.000101	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism—AGT—atherosclerosis	3.99e-06	0.000101	CbGpPWpGaD
Domperidone—DRD2—Signaling by GPCR—MAPK3—atherosclerosis	3.98e-06	0.0001	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—GPX1—atherosclerosis	3.96e-06	0.0001	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—CETP—atherosclerosis	3.96e-06	9.99e-05	CbGpPWpGaD
Domperidone—CYP2B6—Metabolism—INS—atherosclerosis	3.95e-06	9.96e-05	CbGpPWpGaD
Domperidone—CYP3A5—Metabolism—PPARG—atherosclerosis	3.93e-06	9.92e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—INS—atherosclerosis	3.93e-06	9.92e-05	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism—APOE—atherosclerosis	3.91e-06	9.87e-05	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—GSTM1—atherosclerosis	3.9e-06	9.85e-05	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism—CAV1—atherosclerosis	3.87e-06	9.78e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—CCL2—atherosclerosis	3.87e-06	9.76e-05	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism—APOA1—atherosclerosis	3.87e-06	9.76e-05	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—CD36—atherosclerosis	3.86e-06	9.75e-05	CbGpPWpGaD
Domperidone—DRD3—GPCR downstream signaling—AKT1—atherosclerosis	3.86e-06	9.74e-05	CbGpPWpGaD
Domperidone—CYP3A5—Metabolism—INS—atherosclerosis	3.86e-06	9.73e-05	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—LPL—atherosclerosis	3.83e-06	9.67e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—IGF1—atherosclerosis	3.8e-06	9.6e-05	CbGpPWpGaD
Domperidone—DRD3—Signaling by GPCR—IL6—atherosclerosis	3.8e-06	9.59e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—SCARB1—atherosclerosis	3.79e-06	9.57e-05	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—GPX1—atherosclerosis	3.74e-06	9.43e-05	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—MTHFR—atherosclerosis	3.66e-06	9.24e-05	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—CD36—atherosclerosis	3.64e-06	9.18e-05	CbGpPWpGaD
Domperidone—CYP2B6—Metabolism—ALB—atherosclerosis	3.62e-06	9.13e-05	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—MMP9—atherosclerosis	3.61e-06	9.12e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—SERPINE1—atherosclerosis	3.61e-06	9.11e-05	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—PPARA—atherosclerosis	3.59e-06	9.06e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—HMGCR—atherosclerosis	3.58e-06	9.04e-05	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—NFKB1—atherosclerosis	3.58e-06	9.03e-05	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—HMOX1—atherosclerosis	3.55e-06	8.95e-05	CbGpPWpGaD
Domperidone—CYP3A5—Metabolism—ALB—atherosclerosis	3.54e-06	8.92e-05	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism—PIK3CG—atherosclerosis	3.53e-06	8.91e-05	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—MAPK8—atherosclerosis	3.52e-06	8.87e-05	CbGpPWpGaD
Domperidone—DRD3—Signaling by GPCR—AKT1—atherosclerosis	3.51e-06	8.85e-05	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—AGT—atherosclerosis	3.48e-06	8.78e-05	CbGpPWpGaD
Domperidone—CYP2B6—Metabolism—NOS3—atherosclerosis	3.46e-06	8.73e-05	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—MTHFR—atherosclerosis	3.45e-06	8.7e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—NOS3—atherosclerosis	3.45e-06	8.7e-05	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—APOE—atherosclerosis	3.41e-06	8.6e-05	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism—PPARG—atherosclerosis	3.41e-06	8.6e-05	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—APOB—atherosclerosis	3.4e-06	8.58e-05	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—PPARA—atherosclerosis	3.38e-06	8.54e-05	CbGpPWpGaD
Domperidone—CYP3A5—Metabolism—NOS3—atherosclerosis	3.38e-06	8.54e-05	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—CAV1—atherosclerosis	3.38e-06	8.52e-05	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—APOA1—atherosclerosis	3.37e-06	8.5e-05	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism—INS—atherosclerosis	3.34e-06	8.43e-05	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—GSTM1—atherosclerosis	3.31e-06	8.34e-05	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—AGT—atherosclerosis	3.28e-06	8.27e-05	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—VEGFA—atherosclerosis	3.25e-06	8.19e-05	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—LPL—atherosclerosis	3.24e-06	8.19e-05	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—STAT3—atherosclerosis	3.21e-06	8.11e-05	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—APOE—atherosclerosis	3.21e-06	8.1e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—ABCA1—atherosclerosis	3.19e-06	8.05e-05	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—CAV1—atherosclerosis	3.18e-06	8.03e-05	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—APOA1—atherosclerosis	3.17e-06	8.01e-05	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—GPX1—atherosclerosis	3.17e-06	7.99e-05	CbGpPWpGaD
Domperidone—CYP2B6—Metabolism—PTGS2—atherosclerosis	3.16e-06	7.99e-05	CbGpPWpGaD
Domperidone—CYP3A5—Metabolism—PTGS2—atherosclerosis	3.09e-06	7.81e-05	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—CD36—atherosclerosis	3.08e-06	7.78e-05	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—PIK3CG—atherosclerosis	3.07e-06	7.76e-05	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—MAPK3—atherosclerosis	3.07e-06	7.75e-05	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism—ALB—atherosclerosis	3.06e-06	7.73e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—CXCL8—atherosclerosis	3.06e-06	7.72e-05	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—TGFB1—atherosclerosis	2.98e-06	7.52e-05	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—PPARG—atherosclerosis	2.97e-06	7.49e-05	CbGpPWpGaD
Domperidone—DRD2—GPCR downstream signaling—AKT1—atherosclerosis	2.95e-06	7.46e-05	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism—NOS3—atherosclerosis	2.93e-06	7.39e-05	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—MTHFR—atherosclerosis	2.92e-06	7.37e-05	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—INS—atherosclerosis	2.91e-06	7.35e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling by GPCR—IL6—atherosclerosis	2.91e-06	7.34e-05	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—PIK3CG—atherosclerosis	2.9e-06	7.31e-05	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—PPARA—atherosclerosis	2.87e-06	7.23e-05	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—PPARG—atherosclerosis	2.8e-06	7.06e-05	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—AGT—atherosclerosis	2.78e-06	7.01e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—MMP9—atherosclerosis	2.77e-06	6.98e-05	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—INS—atherosclerosis	2.74e-06	6.92e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—HMOX1—atherosclerosis	2.74e-06	6.91e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—NFKB1—atherosclerosis	2.74e-06	6.91e-05	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—APOE—atherosclerosis	2.72e-06	6.86e-05	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—CAV1—atherosclerosis	2.69e-06	6.8e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—MAPK8—atherosclerosis	2.69e-06	6.79e-05	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—APOA1—atherosclerosis	2.69e-06	6.79e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling by GPCR—AKT1—atherosclerosis	2.68e-06	6.77e-05	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism—PTGS2—atherosclerosis	2.68e-06	6.76e-05	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—ALB—atherosclerosis	2.67e-06	6.73e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—APOB—atherosclerosis	2.62e-06	6.62e-05	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—NOS3—atherosclerosis	2.55e-06	6.44e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—GSTM1—atherosclerosis	2.55e-06	6.44e-05	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—ALB—atherosclerosis	2.51e-06	6.35e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—LPL—atherosclerosis	2.5e-06	6.32e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—VEGFA—atherosclerosis	2.48e-06	6.27e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—STAT3—atherosclerosis	2.46e-06	6.21e-05	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—PIK3CG—atherosclerosis	2.45e-06	6.19e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—GPX1—atherosclerosis	2.44e-06	6.17e-05	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—NOS3—atherosclerosis	2.4e-06	6.07e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—CD36—atherosclerosis	2.38e-06	6e-05	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—PPARG—atherosclerosis	2.37e-06	5.98e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—MAPK3—atherosclerosis	2.35e-06	5.93e-05	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—PTGS2—atherosclerosis	2.33e-06	5.89e-05	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—INS—atherosclerosis	2.32e-06	5.86e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—TGFB1—atherosclerosis	2.28e-06	5.75e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—MTHFR—atherosclerosis	2.25e-06	5.69e-05	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—IL6—atherosclerosis	2.24e-06	5.67e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—PPARA—atherosclerosis	2.21e-06	5.58e-05	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—PTGS2—atherosclerosis	2.2e-06	5.55e-05	CbGpPWpGaD
Domperidone—CYP3A7—Metabolism—AKT1—atherosclerosis	2.15e-06	5.43e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—AGT—atherosclerosis	2.14e-06	5.41e-05	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—ALB—atherosclerosis	2.13e-06	5.38e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—APOE—atherosclerosis	2.1e-06	5.3e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—CAV1—atherosclerosis	2.08e-06	5.25e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—APOA1—atherosclerosis	2.07e-06	5.24e-05	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—AKT1—atherosclerosis	2.07e-06	5.23e-05	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—NOS3—atherosclerosis	2.04e-06	5.14e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—PIK3CG—atherosclerosis	1.89e-06	4.78e-05	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—PTGS2—atherosclerosis	1.86e-06	4.7e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—PPARG—atherosclerosis	1.83e-06	4.61e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—INS—atherosclerosis	1.79e-06	4.53e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—IL6—atherosclerosis	1.72e-06	4.34e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—ALB—atherosclerosis	1.64e-06	4.15e-05	CbGpPWpGaD
Domperidone—CYP2B6—Metabolism—AKT1—atherosclerosis	1.59e-06	4.01e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—AKT1—atherosclerosis	1.58e-06	4e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—NOS3—atherosclerosis	1.57e-06	3.97e-05	CbGpPWpGaD
Domperidone—CYP3A5—Metabolism—AKT1—atherosclerosis	1.55e-06	3.92e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—PTGS2—atherosclerosis	1.44e-06	3.63e-05	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism—AKT1—atherosclerosis	1.35e-06	3.4e-05	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—AKT1—atherosclerosis	1.17e-06	2.96e-05	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—AKT1—atherosclerosis	1.11e-06	2.79e-05	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—AKT1—atherosclerosis	9.36e-07	2.36e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—AKT1—atherosclerosis	7.23e-07	1.82e-05	CbGpPWpGaD
